Tabbassum Shikalgar

About the Author

Tabbassum Shikalgar is a distinguished pharmacologist and researcher whose work bridges the gap between laboratory science and clinical application, with a focus on cardiovascular and renal health. Holding advanced degrees in pharmacology, she has dedicated her career to investigating the protective mechanisms of pharmaceutical agents against oxidative stress and toxicity. Her groundbreaking studies on drug interactions have contributed significantly to the understanding of cardioprotective therapies, particularly in models of doxorubicin-induced damage. Through meticulous experimentation and data-driven analysis, Shikalgar's research emphasizes innovative combinations of medications like Nebivolol and Gemfibrozil to mitigate nephrotoxicity and cardiotoxicity. As an educator and mentor, she inspires the next generation of scientists to explore the therapeutic potential of pharmacology in combating chronic diseases. Her publications serve as vital resources for researchers and clinicians seeking evidence-based solutions in toxicology and pharmacology.